Skip to main content
. 2022 Feb 8;71(5):1137–1148. doi: 10.2337/db21-0839

Table 4.

GREML-SC and GREML-LDMS estimates for individuals with diabetes using the UKB genotype data

Phenotype Diabetes (N = 26,387) Diabetes: type 2 only (N = 18,198) No diabetes (N = 26,387) Diabetes and no diabetes (N = 52,774)
Proportion of cases n V(G)/V(p) (SE) Proportion of cases n V(G)/V(p) (SE) V(G)/V(p) (SE) V(G)/V(p) (SE)
GREML-SC GREML-LDMS GREML-LDMS GREML-LDMS GREML-LDMS
DR 0.541 11,739 0.110 (0.041) 0.166 (0.130) 0.514 7,516 0.029 (0.199) NA NA
DKD 0.256 7,707 0.108 (0.064) 0.291 (0.196) 0.259 4,969 0.237 (0.300) 0.453 (0.15) 0.217 (0.089)
Macroalbuminuria 0.029 13,246 0.001 (0.034) 0.000 (0.119) 0.026 9,332 NA NA 0.026 (0.085)
Microalbuminuria 0.238 13,246 0.110 (0.037) 0.250 (0.119) 0.230 9,332 0.214 (0.163) 0.155 (0.201) 0.226 (0.079)
CVD 0.159 17,540 0.081 (0.028) 0.183 (0.093) 0.170 11,506 0.208 (0.139) 0.176 (0.069) 0.085 (0.041)
MI 0.094 16,310 0.097 (0.031) 0.256 (0.100) 0.099 10,610 0.192 (0.149) 0.278 (0.072) 0.141 (0.043)
Stroke any 0.087 16,002 0.041 (0.030) 0.348 (0.101) 0.095 10,434 0.590 (0.151) NA 0.199 (0.044)
Stroke infarct 0.042 15,429 0.000 (0.029) 0.283 (0.106) 0.047 10,030 0.330 (0.158) 0.141 (0.073) 0.167 (0.045)

GREML-LDMS estimates were for individuals with 1) diabetes (both type 1 and type 2), 2) type 2 diabetes only, 3) without diabetes, and 4) groups with diabetes and no diabetes combined using the UKB imputed data. Individuals with no diabetes (N = 26,387) in this table were randomly sampled from a pool of 296,315 individuals with no diabetes in the UKB data. Estimates for the last column were obtained from combining groups with diabetes and no diabetes (N = 52,774). N, number of total samples in the group; n, number of samples without missing phenotype; NA, under GREML-LDMS, the GREML analysis failed to run due to the small sample size; V(G)/V(p), proportion of phenotypic variance explained by genotypes (i.e., heritability, as observed in the study population).